GlassScriptPhysician profile
Heather Ca Lenz
NPI 1578112207
$2,907.89
in general payments reported to CMS, 2019-2025
16 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $144 · 2021: $414 · 2022: $1,622 · 2023: $171 · 2024: $402 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,625.72 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $212.96 | 2024 | Sotyktu |
| Genzyme Corporation | $172.64 | 2022-2025 | |
| Abiomed | $171.67 | 2024 | Impella |
| Regeneron Pharmaceuticals, INC. | $147.70 | 2023 | Dupixent |
| Boston Scientific Corporation | $114.02 | 2021-2025 | Watchman Access System, Watchman Flx |
| Abbvie INC. | $103.31 | 2022-2023 | |
| Hollister Incorporated | $78.56 | 2021 | |
| Clarus Therapeutics INC. | $64.91 | 2021 | |
| Allergan, INC. | $56.43 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $55.39 | 2022-2024 | Dupixent |
| Dendreon Pharmaceuticals LLC | $29.82 | 2022 | |
| 180 Medical, INC. | $26.74 | 2021 | |
| Convatec INC. | $20.57 | 2021 | |
| Acerus Pharmaceuticals Corporation | $15.28 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $12.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Lenz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.